GLUE
Monte Rosa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.66
+9.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 24.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.87x
- Price / sales
- 31.66x
- Price / cash flow
- -37.78x
Enterprise value
- Enterprise value
- $326.3M
- EV / sales
- 11.36x
- EV / EBITDA
- -2.09x
- EV / EBIT
- -1.79x
- Market cap
- $909.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026